“AbbVie is honored to be recognized once again as a top Contract Manufacturer by Life Science Leader,” said Azita Saleki-Gerhardt, Ph.D., President, Operations. “It is a privilege to achieve the top ranking in all six award criteria for the fourth year in a row. We are extremely proud of this achievement, as it recognizes our efforts to provide the highest quality and consistent support and services for our partners and their patients.”
AbbVie Contract Manufacturing has received Life Science Leader CMO Awards in all core awards categories; for 2018, including: Quality, Reliability, Capabilities, Expertise, Compatibility, and Service.
AbbVie was also recognized again with Specialty Awards in the categories of Innovation, On-time, Reputation, Right First Time, State-of-the-Art, and Strength of Science.
Life Science Leader and its independent research partner, Industry Standard Research (ISR), evaluated 110 CMOs in 23 categories based on sponsor company opinions provided via survey. Sponsors may only review CMOs they have outsourced to in the preceding 18 months. ISR collects and analyzes feedback, as well as conducts primary research, to select award recipients.
For more than 35 years, AbbVie has provided CMO services for biologics, potent drugs, drug products, fermentation, prefilled syringes, hot melt extrusion, and APIs.
Louis Garguilo, Life Science Leader Chief Editor and Conference Chair, Outsourced Pharma, says “Each year, the value that CMOs bring to individual biotech and pharma companies increases, as does the overall importance of the service sector to our entire (and global) drug development and manufacturing industry”.
The magazine has issued CMO Awards annually since 2011, and AbbVie has received recognition each year.
Jennifer Cannon, Vice President, Operations Contract Manufacturing, says “This is a significant award, as it is based on operational performance as rated by our current clients, demonstrating their level of satisfaction at our effectiveness and efficiency. This recognition is shared across AbbVie Operations as a whole, as our contract manufacturing capabilities could not be delivered without close partnership with all functional areas”.